CLEVELAND, Dec. 30, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies and delivering related services for the clinical trials industry, today announced top ranking content in the Clinical Leader Top 10 of 2015. A total of 5 DATATRAK authored articles were highlighted in the annual recap, more than any other source, with top spots in the White Paper and Case Study categories.
"DATATRAK has set the standard for technology innovation to simplify clinical research. We are thrilled that our content resonates with clinical trial professionals and remain dedicated to delivering meaningful insight. Our customers tell us that it's our unique combination of expertise in both technology and clinical trials that helps them achieve their goals," said Laurence P. Birch, Chairman and CEO, DATATRAK.
DATATRAK features include:
- "Technology Trends That Will Transform Clinical Trials" – Top White Paper of 2015
- "EDC versus Paper: A Head To Head Comparison" – Top Case Study of 2015
- "Reduce Queries By Up To 70% With eSource" - #3 Case Study of 2015
- "Is Unified Data A Solution For Clinical Trials?" - #2 Contributed Article
- "Mitigating Risk In Clinical Trials: The Study Protocol" - #8 Contributed Article
DATATRAK International, the leader in developing cloud-based, unified dClinical™ platform, is a worldwide technology and consulting company serving the clinical trials industry. The company delivers a portfolio of software solutions that safely accelerate clinical research, from Concept to Cure®.
Tweet: DATATRAK Expertise Tops @ClinicalLeader1 Top 10 Content Lists of 2015 http://ow.ly/WtB15
DATATRAK International is a worldwide technology and services Company delivering Unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Chicago, IL; Cary Research Triangle Park (RTP), North Carolina; Bryan, Texas; and Cleveland, Ohio. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.